Anavex Life Sciences Corp (AVXL)

[bas2020]

I thought it a bit peculiar that P3 was not being scheduled earlier than first of next year. It would seem that Anavex, as well as the FDA, would want to move more rapidly if it's deemed P3 is necessary.

Perhaps it's because Anavex needs time to arrange the needed partnership for funding...or it is purposely delayed to allow the FDA time to analyze and determine if BTD is warranted, not having to spend any money in the preparation of P3? Certainly more questions than answers.